CEO: Robert Azelby

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Alder BioPharmaceuticals Inc is a biotechnology company. It is engaged in the discovery, development, and commercialization of therapeutic antibodies addresses diseases with limited medical options. The company operates across the U.S and Australia.


Key numbers

Market Capitalization:1578547209
Shares Outstanding: 83609492
Float:
Next Earning Date:2019-11-19
TTm EPS: -4.4532
TTm Dividend Rate:
200 days moving average:12.71
50 days moving average: 14.4
One day percent Change: 0



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,